Prostate Cancer Clinical Trials in Austin, TX

Prostate Cancer Clinical Trials in Austin, TX

View the best 10 prostate cancer medical studies in Austin, Texas. Access promising new therapies by applying to a Austin-based Prostate Cancer clinical trial.

Trials in Austin, Texas

Here are the top 10 medical studies for prostate cancer in Austin, Texas

Image of Moffitt Cancer Center in Tampa, United States.

KPT-8602

XPO1 inhibitor

Recruiting1 awardPhase 1 & 2
This trial will assess the safety, tolerability, and preliminary efficacy of KPT-8602, an oral XPO1 inhibitor, in patients with relapsed/refractory multiple myeloma, metastatic colorectal cancer, metastatic castration resistant prostate cancer, higher risk myelodysplastic syndrome, acute myeloid leukemia, and newly diagnosed intermediate/high-risk MDS.
Image of START Midwest in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug called NGM831 alone or with other drugs in patients with advanced or spreading solid tumors. The goal is to see if these treatments can help stop the cancer or help the immune system fight it better. One of the drugs being tested has been widely studied and used in various cancers, showing significant improvements in survival rates and being effective in combination with other treatments.
Image of University of Alabama at Birmingham (UAB) in Birmingham, United States.

Standard of Care Proton Therapy +3 More

Proton Beam Therapy

Recruiting1 award
This trial compares the quality of life, toxicity, and disease control of men with prostate cancer treated with proton therapy vs. IMRT.
Image of Houston Metro Urology in Houston, United States.

Radiotherapy +1 More

Radiation

Recruiting2 awardsPhase 3
This trial is testing if adding a new medication to standard prostate cancer treatments can better delay the spread of cancer or death. The combination works by blocking male hormones, killing cancer cells, and lowering hormone levels.
Image of The Stamford Hospital in Stamford, United States.

Relugolix

Gonadotropin-Releasing Hormone (GnRH) Antagonist

Verified
Recruiting1 award
"This trial aims to gather real-world information on how safe and effective ORGOVYX is for patients with prostate cancer in regular clinical settings. It will also look at how patients respond to treatment with
Image of Mayo Clinic Hospital in Phoenix, United States.

Darolutamide +1 More

Androgen Receptor Inhibitor

Recruiting1 awardPhase 3
This trial is researching if a combination of ADT and darolutamide can help men with prostate cancer at high risk of biochemical recurrence (BCR) live longer without their cancer getting worse.
Image of University of Arizona Cancer Center in Phoenix, United States.

Prednisone +1 More

Corticosteroid

Recruiting0 awardsPhase 2 & 3
This trial is testing a new combination of drugs for prostate cancer that has spread and is no longer responding to hormone therapy.
Image of Urology Centers of Alabama in Homewood, United States.

R-flurbiprofen

Nonsteroidal Anti-inflammatory Drug

Recruiting1 awardPhase 2
This trial is studying how well R-flurbiprofen works in treating patients with localized prostate cancer at risk of recurrence following radiation therapy and/or prostatectomy.
Image of Mayo Clinic Hospital in Phoenix, United States.

Multiparametric Magnetic Resonance Imaging

Diagnostic Test

Recruiting1 award1 criteria
This trial looks at how well MRI works in finding and staging prostate cancer, which may help treatment planning.
Image of Urological Associates of Southern Arizona, P.C . in Tucson, United States.

PF-06821497

BCL-2 Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.